1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients

BACKGROUND: Following solid-organ transplantation (SOT), the optimal dose of primary (val)ganciclovir (v(gcv)) prophylaxis against CMV infection is debated, and breakthrough infection and treatment-limiting side effects are frequently seen. Rates and risk factors for CMV prophylaxis breakthrough and...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Mark Poulsen, Lodding, Isabelle Paula, Mocroft, Amanda, Sørensen, Søren Schwartz, Perch, Michael, Rasmussen, Allan, Gustafsson, Finn, Lundgren, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253855/
http://dx.doi.org/10.1093/ofid/ofy210.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253855/
http://dx.doi.org/10.1093/ofid/ofy210.1425

Ejemplares similares